Search Results - "Walenkamp, A.M.E."

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review by Ormel, H.L., Schoot, G.G.F., Sluiter, W.J., Jalving, M., Gietema, J.A., Walenkamp, A.M.E.

“…Objective Exercise interventions benefit cancer patients. However, only low numbers of patients adhere to these interventions. This review aimed to identify…”
Get full text

Rectal and colon cancer: Not just a different anatomic site by Tamas, K, Walenkamp, A.M.E, de Vries, E.G.E, van Vugt, M.A.T.M, Beets-Tan, R.G, van Etten, B, de Groot, D.J.A, Hospers, G.A.P

“…Highlights • Neoadjuvant radiotherapy is administered only for rectal cancer. • There is a lack of robust evidence for adjuvant chemotherapy in rectal cancer…”
Get full text

Cancer treatment induced metabolic syndrome: improving outcome with lifestyle by Westerink, N.L, Nuver, J, Lefrandt, J.D, Vrieling, A.H, Gietema, J.A, Walenkamp, A.M.E

“…Highlights • Cancer treatment related morbidity impairs long-term survival. • The aetiology of the cancer treatment induced metabolic syndrome is…”
Get full text

The chemokine network, a newly discovered target in high grade gliomas by Domanska, U.M, Kruizinga, R.C, den Dunnen, W.F.A, Timmer-Bosscha, H, de Vries, E.G.E, Walenkamp, A.M.E

“…Abstract Chemokines are small cytokines, characterised by their ability to induce directional migration of cells by binding to chemokine receptors. They are…”
Get full text

P51. Pregnancy stimulates cerebellar hemangioblastoma growth in von Hippel-Lindau disease by Frantzen, C, Kruizinga, R.C, van Asselt, S.J, Zonnenberg, B.A, Lenders, J.W.M, de Herder, W.W, Walenkamp, A.M.E, Giles, R.H, Hes, F.J, Sluiter, W.J, Links, T.P, van Pampus, M.G

Get full text

1812MO Effects of oncologic rehabilitation during adjuvant endocrine therapy in overweight or obese patients with breast cancer by Ormel, H.L., Schröder, C.P., Van der Schoot, G.G.F., Van der Velden, A., Poppema, B.J., Reyners, A.K.L., Walenkamp, A.M.E.

Get full text

A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study by Brahm, C.G., van Linde, M.E., Labots, M., Kouwenhoven, M.C.M., Sanchez Aliaga, E., Enting, R.H., Appelman, A.P.A., Nuver, J., Walenkamp, A.M.E., Verheul, H.M.W.

Get full text

436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study by Brahm, C.G., van Linde, M.E., Labots, M., Kouwenhoven, M.C.M., Sanchez Aliaga, E., Enting, R.H., Appelman, A.P.A., Nuver, J., Walenkamp, A.M.E., Verheul, H.M.W.

“…Glioblastoma, the most common primary brain tumour in adults, universally recurs with dismal prognosis. To date, clinical trials with protein kinase inhibitors…”
Get full text

Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader by Walenkamp, A.M.E, Scharringa, J, Schramel, F.M.N.H, Coenjaerts, F.E.J, Hoepelman, I.M

“…Macrophages and monocytes are adherent phagocytic cells which play an important role in host defence against the yeast-like fungus Cryptococcus neoformans…”
Get full text

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework by de Hosson, L.D., van Veenendaal, L.M., Schuller, Y., Zandee, W.T., de Herder, W.W., Tesselaar, M.E.T., Klümpen, H.J., Walenkamp, A.M.E.

“…Assessment of clinical benefit of systemic treatments of rare diseases including gastroenteropancreatic neuroendocrine tumours (GEP-NET) is challenging…”
Get full text

Vascular damage and pulmonary function in very long-term survivors of testicular cancer (TC) treated with cisplatin-based chemotherapy (CT) by Stelwagen, J., Lubberts, S., Steggink, L.C., Steursma, G., Kruyt, L.M., Donkerbroek, J.W., van Roon, A.M., van Gessel, A.I., van de Zande, S.C., Meijer, C., Wempe, J.B., Gräfin zu Eulenburg, C.H., Nuver, J., Walenkamp, A.M.E., Lefrandt, J.D., Gietema, J.A.

Get full text

Use of Video-consultation is Feasible During Follow-up Care of Patients with a Neuroendocrine Tumour by Bouma, G., de Hosson, L.D., van Essen, H., de Vries, E.G.E., de Groot, D.J.A., Walenkamp, A.M.E.

Get full text

O10.05FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS by Taal, W., Oosterkamp, H.M., Walenkamp, A.M.E., Dubbink, H.J., Beerepoot, L.V., Hanse, M., Buter, J., Honkoop, A., Boerman, D., Vos, F.Y.F., Dinjens, W.N.M., Enting, R.H., Taphoorn, M.J.B., van den Berkmortel, F.W.P.J., Jansen, R., Brandsma, D., Bromberg, J.E., van Heuvel, I., Vernhout, R.M., van der Holt, B., van den Bent, M.J.

“…INTRODUCTION: Treatment options for recurrent glioblastoma remain limited, with only modest activity of second line chemotherapy. Despite the absence of well…”
Get full text

IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB by French, P., Erdem-Eraslan, L., Kros, J. M., Oosterkamp, H. M., Walenkamp, A. M. E., Beerepoot, L., Hanse, M., Buter, J., Honkoop, A., van der Holt, B., Vernhout, R. M., Sillevis Smitt, P. A. E., Taal, W., van den Bent, M. J.

“…BACKGROUND: (blind field). METHODS: RNA expression profiling was performed using DASL (Illumina) on 185 samples of which 113 were derived from BELOB trial…”
Get full text

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia by Kruizinga, R.C., de Jonge, H.J.M., Kampen, K.R., Walenkamp, A.M.E., de Bont, E.S.J.M.

“…In AML high VEGFA protein expression correlates with poor overall and relapse‐free survival (OS/RFS). To date, the relevance of the various VEGFA isoforms is…”
Get full text

Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure by Walenkamp, A.M.E., Chaka, W.S., Verheul, A.F.M., Vaishnav, V.V., Cherniak, R., Coenjaerts, F.E.J., Hoepelman, I.M.

“…We studied the cytokine profile of peripheral blood mononuclear cells after stimulation with various cryptococcal strains or its purified cell wall components…”
Get full text

Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure by Walenkamp, A.M.E., Chaka, W.S., Verheul, A.F.M., Vaishnav, V.V., Cherniak, R., Coenjaerts, F.E.J., Hoepelman, I.M.

“…Abstract We studied the cytokine profile of peripheral blood mononuclear cells after stimulation with various cryptococcal strains or its purified cell wall…”
Get full text